This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Aug 4;128(5):612-3.

doi: 10.1182/blood-2016-06-721092.

Versican vs versikine: tolerance vs attack

Michael Schmitt¹

Affiliations

PMID: 27492311
DOI: 10.1182/blood-2016-06-721092

Free article

Comment

Versican vs versikine: tolerance vs attack

Michael Schmitt. Blood. 2016.

Free article

. 2016 Aug 4;128(5):612-3.

doi: 10.1182/blood-2016-06-721092.

Author

Michael Schmitt¹

Affiliation

¹ HEIDELBERG UNIVERSITY HOSPITAL.

PMID: 27492311
DOI: 10.1182/blood-2016-06-721092

No abstract available

PubMed Disclaimer

Comment on

Immunoregulatory roles of versican proteolysis in the myeloma microenvironment.
Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, Leith C, Maroulakou I, Callander N, Miyamoto S, Hematti P, Apte SS, Asimakopoulos F. Hope C, et al. Blood. 2016 Aug 4;128(5):680-5. doi: 10.1182/blood-2016-03-705780. Epub 2016 Jun 3. Blood. 2016. PMID: 27259980 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations